Armistice Capital’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
JSP
CS
CIP
BCM
Armistice Capital's TNDM Position: Q2 2021 in Review
Armistice Capital sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 100,000 shares — an estimated $8.82M sold.
Armistice Capital first reported a position in TNDM in Q1 2021 and held it in 1 quarter. The position peaked at $8.82M in Q1 2021. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.
- Armistice Capital reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
- Armistice Capital sold 100,000 Tandem Diabetes Care shares in Q2 2021, an estimated $8.82M.
- Armistice Capital first reported a position in Tandem Diabetes Care in Q1 2021 and held it in 1 quarter.
- Armistice Capital's Tandem Diabetes Care position peaked at $8.82M in Q1 2021.
- 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.
Based on Armistice Capital's 13F filing for Q2 2021, filed 16 Aug 2021.